InvestorsHub Logo
Followers 0
Posts 846
Boards Moderated 0
Alias Born 07/10/2014

Re: norman22 post# 22739

Friday, 09/26/2014 10:47:32 PM

Friday, September 26, 2014 10:47:32 PM

Post# of 48316
Norman, I don't know how much experience you have with investing or bio, so forgive me for covering basics.
Most institutions will not buy a stock, no matter how great, until a P2 is complete. Institutions drive the PPS more than anything (on a sustainable level), retail may do a P&D, but institutions are the driving force for long term.
The stock is growing, more importantly, the company is taking steps that a growing company should take. You have researchers and scientists tying their future to a job with ONCS, and ONCS is increasing their burn rate by hiring people that are not necessary for ImmunoPulse. So ONCS is not a one trick pony, or at least they dont think they are.
We already know what is going to be presented on Sunday and PR Monday, so its not about potential disappointment, its about potential surprise. I don't see it going lower, I see it going higher, but by how much? 5% if its just P2 data and yada yada. Something better could be 20%, how does the market take this? 50%? Partnership? In 12 months your ROI will be very impressive, in 3 months I don't know. Some can afford to wait, others can not. Monday is not the big event. A partnership is coming, the conditions of that is the big event